Here are targeted protocols based on specific goals
Sheng Y, Qi S, Hu R, Zhao J, Rui W, Miao Y, Ma J, Yang Q (2019) Identification of blood microRNA alterations in patients with severe active alopecia areata
Stanko et al., 2010
Developing anti-inflammatory therapeutics for patients with osteoarthritis
T2DM is characterized by presenting various defects at a biochemical and pathophysiological level, which are associated with peripheral insulin resistance, increased hepatic glucose production, altered levels of intestinal hormones that regulate insulin and glucagon function, decrease and failure of pancreatic cells function, as well as additional mechanisms that are related to inflammation (Villarreal-Prez et al., 2014